{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:10:04Z","timestamp":1790536204356,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T00:00:00Z","timestamp":1322611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s10875-011-9617-4","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T14:27:36Z","timestamp":1322663256000},"page":"230-237","source":"Crossref","is-referenced-by-count":23,"title":["Radioligand-Binding Assay Reveals Distinct Autoantibody Preferences for Type I Interferons in APS I and Myasthenia Gravis Subgroups"],"prefix":"10.1007","volume":"32","author":[{"given":"Liv","family":"Hapnes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bergithe E. V.","family":"Oftedal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jone F.","family":"Owe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Meager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eystein S.","family":"Husebye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette S. B\u00f8e","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,30]]},"reference":[{"key":"9617_CR1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng1297-399","volume":"17","author":"The Finnish German APECED Consorttium","year":"1997","unstructured":"The Finnish German APECED Consorttium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Nat Genet. 1997;17:399\u2013403.","journal-title":"Nat Genet"},{"key":"9617_CR2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng1297-393","volume":"17","author":"K Nagamine","year":"1997","unstructured":"Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, et al. Positional cloning of the APECED gene. Nat Genet. 1997;17:393\u20138.","journal-title":"Nat Genet"},{"key":"9617_CR3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.1075958","volume":"298","author":"MS Anderson","year":"2002","unstructured":"Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, et al. Projection of an immunological self shadow within the thymus by the aire protein. Science. 2002;298:1395\u2013401.","journal-title":"Science"},{"key":"9617_CR4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.4049\/jimmunol.178.2.1208","volume":"178","author":"E Kekalainen","year":"2007","unstructured":"Kekalainen E, Tuovinen H, Joensuu J, Gylling M, Franssila R, Pontynen N, et al. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Immunol. 2007;178:1208\u201315.","journal-title":"J Immunol"},{"key":"9617_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2009.02090.x","volume":"265","author":"ES Husebye","year":"2009","unstructured":"Husebye ES, Perheentupa J, Rautemaa R, Kampe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J Intern Med. 2009;265:514\u201329.","journal-title":"J Intern Med"},{"key":"9617_CR6","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pmed.0030289","volume":"3","author":"A Meager","year":"2006","unstructured":"Meager A, Visvalingam K, Peterson P, Moll K, Murumagi A, Krohn K, et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006;3:e289.","journal-title":"PLoS Med"},{"key":"9617_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","volume":"202","author":"S Pestka","year":"2004","unstructured":"Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev. 2004;202:8\u201332.","journal-title":"Immunol Rev"},{"key":"9617_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jc.2003-030279","volume":"89","author":"A Soderbergh","year":"2004","unstructured":"Soderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2004;89:557\u201362.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9617_CR9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","volume":"207","author":"K Kisand","year":"2010","unstructured":"Kisand K, Boe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207(2):299\u2013308.","journal-title":"J Exp Med"},{"issue":"2","key":"9617_CR10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","volume":"207","author":"A Puel","year":"2010","unstructured":"Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207(2):291\u20137.","journal-title":"J Exp Med"},{"key":"9617_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/jc.2006-1873","volume":"92","author":"AS Wolff","year":"2007","unstructured":"Wolff AS, Erichsen MM, Meager A, Magitta NF, Myhre AG, Bollerslev J, et al. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab. 2007;92:595\u2013603.","journal-title":"J Clin Endocrinol Metab"},{"key":"9617_CR12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biochi.2007.04.018","volume":"89","author":"P Fitzgerald-Bocarsly","year":"2007","unstructured":"Fitzgerald-Bocarsly P, Feng D. The role of type I interferon production by dendritic cells in host defense. Biochimie. 2007;89:843\u201355.","journal-title":"Biochimie"},{"key":"9617_CR13","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1182\/blood-2008-03-144634","volume":"112","author":"K Kisand","year":"2008","unstructured":"Kisand K, Link M, Wolff AS, Meager A, Tserel L, Org T, et al. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. Blood. 2008;112:2657\u201366.","journal-title":"Blood"},{"key":"9617_CR14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","volume":"132","author":"A Meager","year":"2003","unstructured":"Meager A, Wadhwa M, Dilger P, Bird C, Thorpe R, Newsom-Davis J, et al. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis. Clin Exp Immunol. 2003;132:128\u201336.","journal-title":"Clin Exp Immunol"},{"key":"9617_CR15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/intimm\/dxg088","volume":"15","author":"H Shiono","year":"2003","unstructured":"Shiono H, Wong YL, Matthews I, Liu JL, Zhang W, Sims G, et al. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor. Int Immunol. 2003;15:903\u201313.","journal-title":"Int Immunol"},{"key":"9617_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/path.2141","volume":"211","author":"P Strobel","year":"2007","unstructured":"Strobel P, Murumagi A, Klein R, Luster M, Lahti M, Krohn K, et al. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol. 2007;211:563\u201371.","journal-title":"J Pathol"},{"key":"9617_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.1.5899.131","volume":"1","author":"TE Feltkamp","year":"1974","unstructured":"Feltkamp TE, van den Berg-Loonen PM, Nijenhuis LE, Engelfriet CP, van Rossum AL, van Loghem JJ, et al. Myasthenia gravis, autoantibodies, and HL-A antigens. Br Med J. 1974;1:131\u20133.","journal-title":"Br Med J"},{"key":"9617_CR18","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1210\/jc.2008-0935","volume":"93","author":"A Meloni","year":"2008","unstructured":"Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, et al. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 2008;93:4389\u201397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9617_CR19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clim.2008.07.002","volume":"129","author":"BE Oftedal","year":"2008","unstructured":"Oftedal BE, Boe Wolff AS, Bratland E, Kampe O, Perheentupa J, Myhre AG, et al. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clin Immunol. 2008;129(1):163\u20139.","journal-title":"Clin Immunol"},{"key":"9617_CR20","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0706487","volume":"358","author":"M Alimohammadi","year":"2008","unstructured":"Alimohammadi M, Bjorklund P, Hallgren A, Pontynen N, Szinnai G, Shikama N, et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med. 2008;358:1018\u201328.","journal-title":"N Engl J Med"},{"key":"9617_CR21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","volume":"57","author":"C Buckley","year":"2001","unstructured":"Buckley C, Newsom-Davis J, Willcox N, Vincent A. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence? Neurology. 2001;57:1579\u201382.","journal-title":"Neurology"},{"key":"9617_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2249.2008.03739.x","volume":"154","author":"A Meager","year":"2008","unstructured":"Meager A, Peterson P, Willcox N. Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes. Clin Exp Immunol. 2008;154:141\u201351.","journal-title":"Clin Exp Immunol"},{"key":"9617_CR23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archneur.1982.00510140016004","volume":"39","author":"CW Olanow","year":"1982","unstructured":"Olanow CW, Lane RJ, Roses AD. Thymectomy in late-onset myasthenia gravis. Arch Neurol. 1982;39:82\u20133.","journal-title":"Arch Neurol"},{"key":"9617_CR24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/eji.201041253","volume":"41","author":"K Kisand","year":"2011","unstructured":"Kisand K, Lilic D, Casanova JL, Peterson P, Meager A, Willcox N. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. Eur J Immunol. 2011;41:1517\u201327.","journal-title":"Eur J Immunol"},{"key":"9617_CR25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0896-8411(88)90067-4","volume":"1","author":"M Schluep","year":"1988","unstructured":"Schluep M, Willcox N, Ritter MA, Newsom-Davis J, Larche M, Brown AN. Myasthenia gravis thymus: clinical, histological and culture correlations. J Autoimmun. 1988;1:445\u201367.","journal-title":"J Autoimmun"},{"key":"9617_CR26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2009.08.018","volume":"216","author":"B Tackenberg","year":"2009","unstructured":"Tackenberg B, Schlegel K, Happel M, Eienbroker C, Gellert K, Oertel WH, et al. Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients. J Neuroimmunol. 2009;216:85\u201391.","journal-title":"J Neuroimmunol"},{"key":"9617_CR27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1196\/annals.1254.055","volume":"998","author":"JA Aarli","year":"2003","unstructured":"Aarli JA, Romi F, Skeie GO, Gilhus NE. Myasthenia gravis in individuals over 40. Ann N Y Acad Sci. 2003;998:424\u201331.","journal-title":"Ann N Y Acad Sci"},{"key":"9617_CR28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","volume":"103","author":"DA Compston","year":"1980","unstructured":"Compston DA, Vincent A, Newsom-Davis J, Batchelor JR. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain. 1980;103:579\u2013601.","journal-title":"Brain"},{"key":"9617_CR29","first-page":"55","volume":"91","author":"LI Alpert","year":"1971","unstructured":"Alpert LI, Papatestas A, Kark A, Osserman RS, Osserman K. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Arch Pathol. 1971;91:55\u201361.","journal-title":"Arch Pathol"},{"key":"9617_CR30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jneuroim.2008.06.017","volume":"201\u2013202","author":"P Strobel","year":"2008","unstructured":"Strobel P, Moritz R, Leite MI, Willcox N, Chuang WY, Gold R, et al. The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens. J Neuroimmunol. 2008;201\u2013202:64\u201373.","journal-title":"J Neuroimmunol"},{"key":"9617_CR31","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/jnnp.2008.152637","volume":"80","author":"N Matsui","year":"2009","unstructured":"Matsui N, Nakane S, Nakagawa Y, Kondo K, Mitsui T, Matsumoto T, et al. Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan. J Neurol Neurosurg Psychiatry. 2009;80:1168\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9617_CR32","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","volume":"65","author":"FE Somnier","year":"2005","unstructured":"Somnier FE. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology. 2005;65:928\u201330.","journal-title":"Neurology"},{"key":"9617_CR33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.2006.00608.x","volume":"183","author":"GO Skeie","year":"2006","unstructured":"Skeie GO, Aarli JA, Gilhus NE. Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurol Scand Suppl. 2006;183:19\u201323.","journal-title":"Acta Neurol Scand Suppl"},{"key":"9617_CR34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2009.08.014","volume":"217","author":"M Kazarian","year":"2009","unstructured":"Kazarian M, Calbo J, Proost N, Carpenter CL, Berns A, Laird-Offringa IA. Immune response in lung cancer mouse model mimics human anti-Hu reactivity. J Neuroimmunol. 2009;217:38\u201345.","journal-title":"J Neuroimmunol"},{"key":"9617_CR35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","volume":"273","author":"RA Miller","year":"1996","unstructured":"Miller RA. The aging immune system: primer and prospectus. Science. 1996;273:70\u20134.","journal-title":"Science"},{"key":"9617_CR36","first-page":"217","volume":"22","author":"E Rosato","year":"2008","unstructured":"Rosato E, Salsano F. Immunity, autoimmunity and autoimmune diseases in older people. J Biol Regul Homeost Agents. 2008;22:217\u201324.","journal-title":"J Biol Regul Homeost Agents"},{"key":"9617_CR37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(68)92893-6","volume":"2","author":"MJ Rowley","year":"1968","unstructured":"Rowley MJ, Buchanan H, Mackay IR. Reciprocal change with age in antibody to extrinsic and intrinsic antigens. Lancet. 1968;2:24\u20136.","journal-title":"Lancet"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9617-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-011-9617-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9617-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:14:48Z","timestamp":1559261688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-011-9617-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,30]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["9617"],"URL":"https:\/\/doi.org\/10.1007\/s10875-011-9617-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,30]]}}}